Oculis Holding AG (OCS) Selling, General & Administrative (2022 - 2026)

Oculis Holding AG (OCS) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.13 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 110.21 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 593.21 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2,715.95
7 Royalty Pharma 33.72 Bn 35.84 Bn - 161.89 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 347.92 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 247.47 Mn
10 Oculis Holding AG 879.09 Mn 590.21 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.08 Mn
Dec 31, 2025 -9.70 Mn
Sep 30, 2025 -8.03 Bn
Jun 30, 2025 -7.39 Mn
Mar 31, 2025 -6.10 Mn
Dec 31, 2024 -6.28 Mn
Sep 30, 2024 -6.17 Bn
Jun 30, 2024 -6.93 Mn
Mar 31, 2024 -5.38 Mn
Dec 31, 2023 -4.89 Mn
Sep 30, 2023 -4.88 Mn
Jun 30, 2023 -5.34 Mn
Mar 31, 2023 -4.37 Mn
Dec 31, 2022 -4.61 Mn
Sep 30, 2022 -2.57 Mn
Jun 30, 2022 -2.88 Mn